Non-enhanced MRI surveillance for HCC: A new tool for all, none or selected patients at risk?

Despite the absence of high-quality randomized controlled trials, the results of meta-analyses and large prospective cohort studies suggest that ultrasound (US) surveillance for hepatocellular carcinoma (HCC) confers clinical benefit, with improved overall survival through detection of very early or early stage HCC leading to increased eligibility for potentially curative local treatments and transplantation.1,2 Moreover, the cost-effectiveness of periodical HCC surveillance was reported in patients with cirrhosis in France and the United States.
Source: Journal of Hepatology - Category: Gastroenterology Authors: Tags: Editorial Source Type: research